INT310948

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.12
First Reported 2007
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 1.63
Pain Relevance 0.29

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytoskeleton (DNAI1) cilium (DNAI1) cytoplasm (DNAI1)
DNAI1 (Homo sapiens)
Pain Link Frequency Relevance Heat
corticosteroid 52 93.00 High High
Inflammation 146 79.60 Quite High
cytokine 2 5.00 Very Low Very Low Very Low
fibrosis 2 5.00 Very Low Very Low Very Low
Inflammatory response 2 5.00 Very Low Very Low Very Low
Inflammatory marker 2 5.00 Very Low Very Low Very Low
headache 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Asthma 198 98.44 Very High Very High Very High
General Immunology 2 87.08 High High
Hypersensitivity 4 85.92 High High
INFLAMMATION 136 79.60 Quite High
Eosinophilia 42 77.56 Quite High
Rhinitis 22 67.40 Quite High
Disease 74 50.00 Quite Low
Pulmonary Disease 104 34.88 Quite Low
Nicotine Addiction 28 25.12 Quite Low
Occupational Lung Diseases 6 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
However, these results should be interpreted with caution as the study design did not allow ICS dose reduction in the follow-up phase (phase 2) and the mean dose of ICS in the control group at the end of the treatment optimizing phase (phase 1) of the study was significantly higher than in the eNO group (567 ?
Negative_regulation (reduction) of ICS
1) Confidence 0.12 Published 2007 Journal Allergy Asthma Clin Immunol Section Body Doc Link PMC2873624 Disease Relevance 0.68 Pain Relevance 0.14
Smith and colleagues examined the use of eNO versus a conventional symptom-based asthma management strategy to assess the frequency of exacerbations and efficacy of ICS reduction based on the two management regimens in a single-blind, placebo-controlled study of 97 patients [85].
Negative_regulation (reduction) of ICS associated with asthma
2) Confidence 0.09 Published 2007 Journal Allergy Asthma Clin Immunol Section Body Doc Link PMC2873624 Disease Relevance 0.95 Pain Relevance 0.16

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox